Brief: L&K Biomed receives patent
07/07/2017 03:28
July 7 (Reuters) - L&K Biomed Co Ltd 156100.KQ :
* Says it receives patent about anti-emap antibody and use
thereof
* Says patent number is 10-2017-0038706
Source text in Korean: https://goo.gl/cjvmnx
Further company coverage: 156100.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on L&K Biomed
See all newsBrief: L&K Biomed says conversion of 5th series convertible bonds into shares
Brief: L&K Biomed says conversion of 5th series convertible bonds into shares
Brief: L&K Biomed lowers conversion price of 5th series convertible bonds to 7,194 won/share
Brief: L&K Biomed issues 6th tranche convertible bonds worth 6 bln won
Brief: L&K Biomed to raise 11.0 bln won in private placement